Table 2 Bronchodilators that have recently been approved in some countries or are currently undergoing clinical development

  • LABAs

 Olodaterol, vilanterol, abediterol

  • LAMAs

 Aclidinium, glycopyrronium, umeclidinium

  • LAMA/LABA combinations

 Glycopyrronium/indacaterol (QVA149), umeclidinium/vilanterol, tiotropium/olodaterol, aclidinium/formoterol, glycopyrronium bromide/formoterol (PT001)

  • MABAs

 GSK-961081, AZD2115

  • LABA/ICS combination

 Fluticasone furoate/vilanterol, mometasone/indacaterol (QMF149)

  • LAMA/LABA/ICS “triple combination inhalers”

 Ciclesonide/tiotropium/formoterol, beclomethasone/formoterol/glycopyrronium, QMF149/glycopyrronium, umeclidinium/vilanterol/fluticasone furoate, GSK961081/fluticasone